Carisma Therapeutics and Moderna Nominate New Cancer Therapy Candidate
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced the recent nomination of its first development candidate under a collaboration with Moderna, Inc. This candidate is an in vivo …
Carisma Therapeutics and Moderna Nominate New Cancer Therapy Candidate Read More